Opportunity Information: Apply for RFA AI 10 027
Apply for RFA AI 10 027
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Biomedical Prevention of HIV Research Education (R25)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Jul 29, 2010 and posted on Jul 29, 2010.
- Applicants must submit their applications by Nov 9, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) .
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Biomedical Prevention of HIV Research Education (R25) funding opportunity is an NIH research education grant issued by the National Institute of Allergy and Infectious Diseases (NIAID). Its central goal is to build a stronger, nationwide U.S. environment that supports community participation in clinical biomedical HIV prevention trials. Rather than funding clinical trials directly, the grant focuses on education, engagement, and trust-building so that people and communities most affected by HIV in the United States have clearer, more accurate information about what biomedical prevention research is, why it is done, how it works, and what participation in a trial actually involves. The intent is to reduce misunderstandings, address barriers to participation, and increase informed engagement with prevention research among populations disproportionately impacted by HIV and AIDS, guided by U.S. surveillance data referenced by CDC.
A key feature of the program is its emphasis on innovative, evidence-based educational strategies. Applicants are expected to propose approaches that are grounded in what has been shown to work, while also being creative and tailored to real-world community needs. The FOA strongly encourages the creation of partnerships at a national scale, bringing together scientists and clinical researchers with educators, media and communications experts, community leaders, and other stakeholder organizations. The underlying idea is that credible, culturally responsive education about HIV prevention trials is most effective when it is co-developed and delivered with trusted community voices and professional communicators, not just researchers alone. These partnerships are meant to strengthen knowledge and understanding of biomedical prevention research in communities with high HIV burden and to help create conditions that make trial participation more accessible and acceptable.
The scope of “clinical biomedical HIV prevention research” in this opportunity is broad. It includes, but is not limited to, HIV vaccine research, microbicide research, pre-exposure prophylaxis (PrEP) research, and “test and treat” strategies aimed at reducing HIV incidence. In practice, this means the educational work supported under the grant could cover how different prevention tools are studied, what phases of clinical research look like, what safety monitoring and ethics protections exist, what informed consent entails, and how community members can make informed decisions about participation. The focus is on improving understanding of the research process itself, not on promoting any single product or intervention.
This FOA uses the NIH Research Education Grant (R25) mechanism. That mechanism is designed to support structured educational activities that complement and strengthen the biomedical research enterprise, particularly by building knowledge, skills, and informed participation. A practical administrative detail included in the announcement is that research education programs supported by this award generally cannot be transferred from one institution to another unless there is a strong justification, which signals NIH’s expectation of stable institutional commitment and capacity over the project period.
In terms of funding, NIAID indicated an intention to commit up to $1.8 million total in fiscal year 2011 to support one award under this FOA. Like many federal opportunities, the award is contingent on the availability of appropriated funds and on receiving a sufficient number of applications that are judged meritorious through the review process. The opportunity is categorized as a discretionary grant in the health area, under CFDA 93.856 (Microbiology and Infectious Diseases Research), and it does not require cost sharing or matching.
Eligibility is broad and includes many types of U.S. organizations capable of leading national educational and partnership-building efforts. Eligible applicants include public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and Native American tribal organizations (other than federally recognized tribal governments). The FOA also explicitly highlights additional eligible applicant types such as faith-based and community-based organizations; Alaska Native and Native Hawaiian Serving Institutions; Hispanic-Serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs). This wide eligibility reflects the program’s emphasis on reaching highly affected communities through institutions that may already have deep community ties, communications reach, or specialized cultural and educational expertise.
For reference, the opportunity number is RFA-AI-10-027, it was posted July 29, 2010, and it originally closed November 9, 2010, with an archive date of December 10, 2010. The full announcement was hosted through the NIH grants guide, and NIH provided standard contact information through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
Frequently Asked Questions (FAQs)
What is the Biomedical Prevention of HIV Research Education (R25) opportunity?
It is an NIH research education grant opportunity focused on improving public and community understanding of clinical biomedical HIV prevention research in the United States. The funding opportunity is issued by the National Institute of Allergy and Infectious Diseases (NIAID) and uses the NIH Research Education Grant (R25) mechanism.
Which NIH institute is sponsoring this funding opportunity?
The opportunity is issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
What is the main goal of this FOA?
The central goal is to build a stronger nationwide U.S. environment that supports community participation in clinical biomedical HIV prevention trials by improving education, engagement, and trust. The intent is to reduce misunderstandings, address barriers to participation, and increase informed engagement in prevention research among populations disproportionately impacted by HIV and AIDS, guided by U.S. surveillance data referenced by CDC.
Does this grant fund clinical trials directly?
No. This opportunity is not designed to fund clinical trials. It supports education, engagement, and trust-building efforts so communities can better understand what biomedical HIV prevention research is and what participation in a trial involves.
What types of activities does the R25 mechanism support in this FOA?
The R25 mechanism supports structured educational activities that complement and strengthen the biomedical research enterprise. In this FOA, that means educational and partnership-building activities intended to improve understanding of biomedical HIV prevention research and informed participation in related clinical trials.
Who is the intended audience for the educational efforts?
The FOA emphasizes reaching people and communities in the United States most affected by HIV, particularly populations disproportionately impacted by HIV and AIDS as indicated by U.S. surveillance data referenced by CDC.
What is meant by “clinical biomedical HIV prevention research” in this FOA?
The scope is broad and includes (but is not limited to) HIV vaccine research, microbicide research, pre-exposure prophylaxis (PrEP) research, and “test and treat” strategies aimed at reducing HIV incidence.
What topics can the educational program cover?
Supported education can address how different prevention tools are studied; what phases of clinical research look like; what safety monitoring and ethics protections exist; what informed consent entails; and what trial participation practically involves so community members can make informed decisions.
Is the goal to promote a specific HIV prevention product or intervention?
No. The focus is on improving understanding of the research process itself rather than promoting any single product or intervention.
What approach does the FOA expect applicants to use for education and outreach?
The FOA emphasizes innovative, evidence-based educational strategies. Applicants are expected to propose approaches grounded in what has been shown to work, while also being creative and tailored to real-world community needs.
Does the FOA encourage partnerships, and if so, what kind?
Yes. The FOA strongly encourages national-scale partnerships that bring together scientists and clinical researchers with educators, media and communications experts, community leaders, and other stakeholder organizations. The intent is for credible, culturally responsive education to be co-developed and delivered with trusted community voices and professional communicators.
Why are national partnerships emphasized?
The FOA is aimed at strengthening knowledge and understanding in communities with high HIV burden across the U.S. National partnerships are positioned as a way to expand reach, strengthen credibility, and improve cultural responsiveness through collaboration among researchers, communicators, and community stakeholders.
How many awards did NIAID plan to make under this FOA?
NIAID indicated an intention to support one award under this FOA, contingent on the availability of appropriated funds and the receipt of a sufficient number of meritorious applications.
How much funding was NIAID planning to commit?
NIAID indicated an intention to commit up to $1.8 million total in fiscal year 2011 to support one award, subject to appropriated funds and the outcome of the peer review process.
Is cost sharing or matching required?
No. The FOA states that cost sharing or matching is not required.
What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.856, Microbiology and Infectious Diseases Research.
What type of grant is this categorized as?
It is categorized as a discretionary grant in the health area.
Which organizations are eligible to apply?
Eligibility is broad and includes: public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and Native American tribal organizations (other than federally recognized tribal governments).
Are community-based and faith-based organizations eligible?
Yes. The FOA explicitly highlights faith-based and community-based organizations among eligible applicant types.
Are minority-serving institutions included in the eligible applicant types?
Yes. The FOA explicitly highlights Alaska Native and Native Hawaiian Serving Institutions; Hispanic-Serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); and related institution types as eligible.
Does the FOA mention anything about transferring an award to another institution?
Yes. The FOA notes that research education programs supported by this award generally cannot be transferred from one institution to another unless there is a strong justification. This signals an expectation of stable institutional commitment and capacity over the project period.
What is the opportunity number for this FOA?
The opportunity number is RFA-AI-10-027.
When was this opportunity posted and when did it close?
It was posted on July 29, 2010. It originally closed on November 9, 2010, with an archive date of December 10, 2010.
Where was the full announcement hosted?
The full announcement was hosted through the NIH grants guide.
Who is listed for technical issues like access or linking problems?
NIH provided standard contact information through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Governors Island National Monument preservation
Previous opportunity: C.A.S.T for Kids
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AI 10 027
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AI 10 027) also looked into and applied for these:
| Funding Opportunity |
|---|
| State Planning and Establishment Grants for the Affordable Care Acts Exchanges Apply for IE HBE 10 001 Funding Number: IE HBE 10 001 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: $1,000,000 |
| Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP HTM) (U19) Apply for RFA AI 10 006 Funding Number: RFA AI 10 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Expanded Social Marketing Project in Nigeria (ESMPIN) Apply for RFA OAA 620 10 016 Funding Number: RFA OAA 620 10 016 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| FY11 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Illinois, Chicago Area). Apply for PA FPH 11 003 Funding Number: PA FPH 11 003 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $402,181 |
| Nutrition and Alcohol Related Health Outcomes (R03) Apply for PA 10 240 Funding Number: PA 10 240 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY11 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Illinois, Chicago Area) Apply for PA FPH 11 003 011753 Funding Number: PA FPH 11 003 011753 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $402,181 |
| Epi Centers for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events (U54) Apply for RFA CI 11 001 Funding Number: RFA CI 11 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R21) Apply for PA 10 243 Funding Number: PA 10 243 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R01) Apply for PA 10 242 Funding Number: PA 10 242 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biobehavioral Research Awards for Innovative New Scientists (BRAINS) (R01) Apply for RFA MH 11 050 Funding Number: RFA MH 11 050 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Alcohol Induced Metabolic and Hepatic Injury (AIMHI) (R01) Apply for RFA AA 11 002 Funding Number: RFA AA 11 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Patient Protection and Affordable Care Act (Affordable Care Act) State Supplemental Funding for Healthy Communities, Tobacco Prevention and Control, Diabetes Prevention and Control, and Behavioral Risk Factor Surveillance System Apply for RFA DP09 90101SUPP10 Funding Number: RFA DP09 90101SUPP10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP HTM) Competitive Revisions (U19) Apply for RFA AI 10 007 Funding Number: RFA AI 10 007 Agency: National Institutes of Health Category: Health Funding Amount: $1,400,000 |
| Mechanisms Mediating Changes in Central Regulation of Bone Mass (R01) Apply for RFA AG 11 006 Funding Number: RFA AG 11 006 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Planning Grant The Money Follows the Person Rebalancing Demonstration Program Apply for CMS 1LI 11 002 Funding Number: CMS 1LI 11 002 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Guidance for Supplemental Funding to Funding Opportunity Announcement (FOA) PS08 802, HIV/AIDS Surveillance Enhancing Laboratory Reporting Apply for CDC RFA PS08 8020302SUPP10 Funding Number: CDC RFA PS08 8020302SUPP10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Grants for Early Medical/Surgical Subspecialists Transition to Aging Research (R03) Apply for RFA AG 11 007 Funding Number: RFA AG 11 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Protection and Affordable Care Act (PPACA) Emerging Infections Program (EIP) Enhancing Epidemiology and Laboratory Capacity (U01) Apply for RFA CI 10 003 Funding Number: RFA CI 10 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $650,000 |
| EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) BUILDING AND STRENGTHENING EPIDEMIOLOGY, LABORATORY AND HEALTH INFORMATION SYSTEMS CAPACITY IN STATE AND LOCAL HEALTH DEPARTMENTS Apply for CDC RFA CI10 1012 Funding Number: CDC RFA CI10 1012 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Patient Protection and Affordable Health Care Act (Affordable Care Act) Pacific Islands Supplemental Funding for Five Year US Affiliated Pacific Island Collaborative Performance Agreement for Tobacco Control, Diabetes Prevention and Control, and the Apply for RFA DP09 90201SUPP10 Funding Number: RFA DP09 90201SUPP10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 10 027", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.